Valuation: Gedeon Richter

Market Cap 2,223B 7.2B 6.29B 5.78B 5.39B 10.22B 685B 10.38B 69.42B 26.99B 337B 27.02B 26.44B 1,161B P/E 2026 *
8.51x
P/E 2027 * 7.81x
Enterprise Value 1,909B 6.18B 5.4B 4.96B 4.63B 8.78B 588B 8.91B 59.59B 23.17B 289B 23.19B 22.7B 997B EV / Sales 2026 *
2.01x
EV / Sales 2027 * 1.76x
Free-Float
72.87%
Yield 2026 *
5.09%
Yield 2027 * 5.45%
1 year 30.92
Extreme 30.925
30.92
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 31/10/2017
Director of Finance/CFO - 30/04/2025
Chief Operating Officer - 31/12/2018
Director TitleAgeSince
Director/Board Member 47 31/03/2017
Chairman 78 31/12/2016
Chairman 90 29/02/2024
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.2B
+1.81%+2.25%+13.40%+84.45% 48B
-2.54%+3.72%+65.71%+113.61% 36.89B
+0.15%+1.26%-3.35%+45.56% 12.37B
+3.71%+3.56%+14.13%+97.20% 11.95B
+0.39%+0.58%+33.25%+119.07% 9.01B
+0.71%+1.75%+53.59%-7.09% 7.05B
+0.68%+2.63%+23.97%+235.28% 6.55B
+9.99%+32.94%-15.69%+27.08% 6.58B
-0.57%+4.59%+26.40%+125.51% 4.36B
Average +3.88%+4.82%+23.49%+93.41% 15.86B
Weighted average by Cap. +1.94%+3.59%+28.31%+92.88%

Financials

2026 *2027 *
Net sales 952B 3.08B 2.69B 2.48B 2.31B 4.38B 293B 4.44B 29.71B 11.55B 144B 11.56B 11.32B 497B 1,024B 3.31B 2.9B 2.66B 2.48B 4.71B 315B 4.78B 31.96B 12.42B 155B 12.44B 12.17B 534B
Net income 259B 840M 734M 675M 629M 1.19B 79.98B 1.21B 8.1B 3.15B 39.31B 3.15B 3.09B 135B 286B 926M 810M 744M 694M 1.32B 88.2B 1.34B 8.93B 3.47B 43.36B 3.48B 3.4B 149B
Net Debt -315B -1.02B -890M -818M -763M -1.45B -96.96B -1.47B -9.82B -3.82B -47.66B -3.82B -3.74B -164B -421B -1.36B -1.19B -1.1B -1.02B -1.94B -130B -1.97B -13.16B -5.11B -63.84B -5.12B -5.01B -220B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,190.00HUF
Average target price
12,931.29HUF
Spread / Average Target
+6.08%

Quarterly revenue - Rate of surprise